Related Experiment Video
Updated: Jul 26, 2025
09:12
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
962
A sticky situation for targeted cancer therapy
Vitalii S Basistyi1, James H Frederich1
1Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
Cell Chemical Biology
|June 16, 2023
Summary
Fusicoccin toxins enhance cancer cell death when combined with interferon-alpha. These toxins promote apoptosis by stabilizing 14-3-3 protein interactions, offering a novel therapeutic strategy.
Area of Science:
- Chemical Biology
- Molecular Oncology
- Immunology
Background:
- Cancer cells often evade apoptosis, necessitating novel therapeutic strategies.
- Interferon-alpha (IFN-α) is an immunomodulatory cytokine with anti-cancer properties.
- Fusicoccin toxins are natural products with known biological activities.
Purpose of the Study:
- To investigate the synergistic effects of fusicoccin toxins and interferon-alpha on cancer cell viability.
- To elucidate the molecular mechanisms underlying the observed synergy.
Main Methods:
- Cell viability assays were performed using various cancer cell lines.
- Apoptosis markers were analyzed using flow cytometry and Western blotting.
- Protein-protein interaction studies focused on 14-3-3 adaptors.
Main Results:
- Fusicoccins significantly potentiated the cytotoxic effects of interferon-alpha in multiple cancer cell types.
- The combination treatment led to increased apoptosis compared to either agent alone.
- Fusicoccins were shown to stabilize 14-3-3 protein-protein interactions, a key step in apoptosis regulation.
Conclusions:
- Fusicoccin toxins and interferon-alpha exhibit a synergistic anti-cancer effect.
- The potentiation of apoptosis by fusicoccins involves modulation of 14-3-3 interactions.
- This study highlights a potential new therapeutic approach for cancer treatment.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.7K
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:18Cancer
48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K